Hospira's ($HSP) board has stuck with F. Michael Ball as he has steered the company through a tough regulatory patch in which it had to invest hundreds of millions of dollars to upgrade its plants. For his efforts, Ball last year came out $1.1 million ahead, with $9.89 million in total compensation, compared with $8.78 million in 2012. Report